Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Asset Writedowns and Impairment (2016 - 2021)

AtriCure (ATRC) has disclosed Asset Writedowns and Impairment for 11 consecutive years, with $82.3 million as the latest value for Q3 2021.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A to $82.3 million in Q3 2021 year-over-year; TTM through Sep 2022 was $81.7 million, a 0.62% decrease, with the full-year FY2021 number at $82.3 million, changed N/A from a year prior.
  • Asset Writedowns and Impairment was $82.3 million for Q3 2021 at AtriCure, up from -$580000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $82.3 million in Q3 2021 to a low of -$580000.0 in Q4 2019.
  • A 4-year average of $9.2 million and a median of $7000.0 in 2018 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: tumbled 107.85% in 2017, then skyrocketed 2506.67% in 2018.
  • AtriCure's Asset Writedowns and Impairment stood at -$15000.0 in 2017, then surged by 2506.67% to $361000.0 in 2018, then crashed by 260.66% to -$580000.0 in 2019, then skyrocketed by 14289.66% to $82.3 million in 2021.
  • Per Business Quant, the three most recent readings for ATRC's Asset Writedowns and Impairment are $82.3 million (Q3 2021), -$580000.0 (Q4 2019), and $512000.0 (Q3 2019).